Found: 3057
Select item for more details and to access through your institution.
Darolutamide does not interfere with OATP‐mediated uptake of docetaxel.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 2, p. 314, doi. 10.1002/ijc.34922
- By:
- Publication type:
- Article
Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable‐risk prostate cancer patients receiving docetaxel: Insights from a randomized trial.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 13, p. 2287, doi. 10.1002/cncr.35274
- By:
- Publication type:
- Article
Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course.
- Published in:
- Diagnostic Pathology, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13000-024-01511-3
- By:
- Publication type:
- Article
PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49675-2
- By:
- Publication type:
- Article
CDK7/CDK9 mediates transcriptional activation to prime paraptosis in cancer cells.
- Published in:
- Cell & Bioscience, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13578-024-01260-2
- By:
- Publication type:
- Article
Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer.
- Published in:
- BJU International, 2024, v. 133, n. 6, p. 671, doi. 10.1111/bju.16208
- By:
- Publication type:
- Article
Influence of Previous Therapy for Neutropenia Caused by Combination Therapy of Ramucirumab and Docetaxel.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2076, doi. 10.3390/cancers16112076
- By:
- Publication type:
- Article
Epigenetic activation of METTL14 promotes docetaxel resistance in prostate cancer by promoting pri‐microRNA‐129 maturation.
- Published in:
- Environmental Toxicology, 2024, v. 39, n. 6, p. 3734, doi. 10.1002/tox.24187
- By:
- Publication type:
- Article
Effect of epirubicin combined with docetaxel on inflammatory factors, cytokines, tumor markers, clinical efficacy and adverse reactions in patients with cervical cancer after surgery.
- Published in:
- European Journal of Gynaecological Oncology, 2024, v. 45, n. 3, p. 160, doi. 10.22514/ejgo.2024.059
- By:
- Publication type:
- Article
Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 716, doi. 10.1007/s10147-024-02485-4
- By:
- Publication type:
- Article
Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6058, doi. 10.3390/ijms25116058
- By:
- Publication type:
- Article
Giving birth after fertility‐sparing treatment for primary leiomyosarcoma of the fallopian tube.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2024, v. 50, n. 6, p. 1051, doi. 10.1111/jog.15919
- By:
- Publication type:
- Article
Baicalin and Baicalein Enhance Cytotoxicity, Proapoptotic Activity, and Genotoxicity of Doxorubicin and Docetaxel in MCF-7 Breast Cancer Cells.
- Published in:
- Molecules, 2024, v. 29, n. 11, p. 2503, doi. 10.3390/molecules29112503
- By:
- Publication type:
- Article
The Investigation of the Subtle Structural Discrepancies between Oryza Sativa Recombinant and Plasma-Derived Human Serum Albumins to Design a Novel Nanoparticle as a Taxane Delivery System.
- Published in:
- Protein Journal, 2024, v. 43, n. 3, p. 544, doi. 10.1007/s10930-024-10194-0
- By:
- Publication type:
- Article
Boosting antitumor efficacy using docetaxel-loaded nanoplatforms: from cancer therapy to regenerative medicine approaches.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, p. 1, doi. 10.1186/s12967-024-05347-9
- By:
- Publication type:
- Article
PET imaging of PD-L1 with a small molecule radiotracer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 6, p. 1578, doi. 10.1007/s00259-024-06663-4
- By:
- Publication type:
- Article
Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-04992-5
- By:
- Publication type:
- Article
Increasing the radiation-induced cytotoxicity by silver nanoparticles and docetaxel in prostate cancer cells.
- Published in:
- Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09506-5
- By:
- Publication type:
- Article
p53 activation enhances the sensitivity of non-small cell lung cancer to the combination of SH003 and docetaxel by inhibiting de novo pyrimidine synthesis.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03337-x
- By:
- Publication type:
- Article
Comparative Study of Genomic DNA Extraction Protocols from Whole Blood for P53 Gene Polymorphism in Persons with and without Prostate Cancer.
- Published in:
- Baghdad Science Journal, 2024, v. 21, n. 3, p. 975, doi. 10.21123/bsj.2023.7981
- By:
- Publication type:
- Article
Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial
- Published in:
- Gastric Cancer, 2024, v. 27, n. 3, p. 571, doi. 10.1007/s10120-024-01471-z
- By:
- Publication type:
- Article
Rheological and Injectability Evaluation of Sterilized Poloxamer-407-Based Hydrogels Containing Docetaxel-Loaded Lipid Nanoparticles.
- Published in:
- Gels (2310-2861), 2024, v. 10, n. 5, p. 307, doi. 10.3390/gels10050307
- By:
- Publication type:
- Article
Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. e635, doi. 10.1093/oncolo/oyae025
- By:
- Publication type:
- Article
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non‐Small‐Cell Lung Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. e681, doi. 10.1093/oncolo/oyae001
- By:
- Publication type:
- Article
A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical Study.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 5, p. 602, doi. 10.3390/pharmaceutics16050602
- By:
- Publication type:
- Article
Integrated aerobic exercise with LDE-docetaxel treatment: a novel approach to combat prostate cancer progression.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-60138-y
- By:
- Publication type:
- Article
Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial).
- Published in:
- PLoS ONE, 2024, v. 19, n. 4, p. 1, doi. 10.1371/journal.pone.0299742
- By:
- Publication type:
- Article
EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1481, doi. 10.3390/cancers16081481
- By:
- Publication type:
- Article
Ganoderma spore lipid ameliorates docetaxel, cisplatin, and 5-fluorouracil chemotherapy-induced damage to bone marrow mesenchymal stem cells and hematopoiesis.
- Published in:
- BMC Complementary Medicine & Therapies, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12906-024-04445-x
- By:
- Publication type:
- Article
Identification of chemoresistance associated key genes-miRNAs-TFs in docetaxel resistant breast cancer by bioinformatics analysis.
- Published in:
- 3 Biotech, 2024, v. 14, n. 5, p. 1, doi. 10.1007/s13205-024-03971-2
- By:
- Publication type:
- Article
Neoadjuvant Chemotherapy in Patients with HER2- Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran.
- Published in:
- Archives of Iranian Medicine (AIM), 2024, v. 27, n. 4, p. 206, doi. 10.34172/aim.2024.30
- By:
- Publication type:
- Article
Sperm-Associated Antigen 5 Knockout Reduces Doxorubicin and Docetaxel Resistance in Triple-Negative Breast Cancer MDA-MB-231 and BT549 Cells.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1269, doi. 10.3390/cancers16071269
- By:
- Publication type:
- Article
Perioperative Chemotherapy for Gastro-Esophageal or Gastric Cancer: Anthracyclin Triplets versus FLOT.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1291, doi. 10.3390/cancers16071291
- By:
- Publication type:
- Article
A Phase II Study of Neoadjuvant Chemoradiotherapy with Docetaxel, Cisplatin and 5-FU Followed by Surgical Resection in the Treatment of Locally Advanced Esophagogastric Junction Cancer and Locally Advanced Esophageal Cancer.
- Published in:
- Clinics & Practice, 2024, v. 14, n. 2, p. 642, doi. 10.3390/clinpract14020051
- By:
- Publication type:
- Article
Clinical study of camrelizumab combined with docetaxel and carboplatin as a neoadjuvant treatment for locally advanced oesophageal squamous cell carcinoma.
- Published in:
- Diseases of the Esophagus, 2024, v. 37, n. 4, p. 1, doi. 10.1093/dote/doad073
- By:
- Publication type:
- Article
Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 4009, doi. 10.3390/ijms25074009
- By:
- Publication type:
- Article
Quantifying Chemotherapy Delivery in Older and Younger Women With Early-Stage Breast Cancer Using Longitudinal Cumulative Dose.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. 311, doi. 10.1093/oncolo/oyad349
- By:
- Publication type:
- Article
Self‐Promoted Targeting Delivery of Nanodrug Through Chemotherapeutic Upregulation of CD47 for Triple Negative Breast Cancer Therapy.
- Published in:
- Advanced Functional Materials, 2024, v. 34, n. 13, p. 1, doi. 10.1002/adfm.202311677
- By:
- Publication type:
- Article
Clinical Benefit from Docetaxel +/− Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 935, doi. 10.3390/cancers16050935
- By:
- Publication type:
- Article
Synthesis and in vitro antitumor activity of galactosamine–docetaxel conjugates.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 3, p. 1, doi. 10.1111/cbdd.14511
- By:
- Publication type:
- Article
A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 3, p. 1, doi. 10.1002/ctm2.1627
- By:
- Publication type:
- Article
Erste klinische und onkologische Erfahrungen mit der Triplet-Therapie beim „high-volume" metastasierten hormonsensiblen Prostatakarzinom.
- Published in:
- Die Urologie, 2024, v. 63, n. 3, p. 254, doi. 10.1007/s00120-023-02253-8
- By:
- Publication type:
- Article
Integrative Metabolomic Analysis of Serum and Selected Serum Exosomal microRNA in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 5, p. 2630, doi. 10.3390/ijms25052630
- By:
- Publication type:
- Article
miR‐203a—A multifaceted regulator modulating cancer hallmarks and therapy response.
- Published in:
- IUBMB Life, 2024, v. 76, n. 3, p. 108, doi. 10.1002/iub.2786
- By:
- Publication type:
- Article
Characterization and Evaluation of Nano-niosomes Encapsulating Docetaxel against Human Breast, Pancreatic, and Pulmonary Adenocarcinoma Cancer Cell Lines.
- Published in:
- Journal of Biomedical Physics & Engineering, 2024, v. 14, n. 2, p. 159, doi. 10.31661/jbpe.v0i0.2401-1708
- By:
- Publication type:
- Article
Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-02962-8
- By:
- Publication type:
- Article
Chemotherapy regimen for recurrent uterine leiomyosarcoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 2, p. 400, doi. 10.1177/10781552231205203
- By:
- Publication type:
- Article
A preliminary mechanistic exploration of the effect of leptin on the docetaxel sensitivity of MDA‑MB‑231 triple‑negative breast cancer cells.
- Published in:
- Molecular & Clinical Oncology, 2024, v. 20, n. 3, p. N.PAG, doi. 10.3892/mco.2024.2722
- By:
- Publication type:
- Article
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 235, doi. 10.1093/oncolo/oyad254
- By:
- Publication type:
- Article
Neoadjuvant Triplet Chemotherapy with Docetaxel, Cisplatin plus 5-Fluorouracil versus Docetaxel, Cisplatin plus S-1 for Advanced Esophageal Squamous cell Carcinoma: Propensity Score Matched Analysis.
- Published in:
- Oncology, 2024, v. 102, n. 3, p. 228, doi. 10.1159/000533790
- By:
- Publication type:
- Article